SALL4 and acute myeloid leukemia: Using the optimized qRT-PCR condition that we established earlier [33], [27], [28], we compared SALL4 expression level in AML patients without treatment (N = 36), AML patients in the complete remission (CR) phase (N = 25), AML patients in the partial remission (PR) phase (N = 7), and healthy controls (N = 30).